Surveillance and management of dysplasia in ulcerative colitis

Sarah A. Rodriguez, Judith (Judy) Collins, Kandice Knigge, Glenn M. Eisen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Recently updated practice guidelines give specific recommendations on surveillance and management of dysplasia in patients with ulcerative colitis. Previous studies of gastroenterologists in the United States and the United Kingdom demonstrated inconsistent surveillance techniques and limited understanding of the implications of dysplasia. Objectives: To demonstrate current surveillance practices and management of dysplasia among U.S. gastroenterologists. Design: An 18-item questionnaire was mailed to 1000 gastroenterologists in the United States who were randomly selected from an American Gastroenterological Association mailing list. Setting: United States. Results: A total of 334 questionnaires were returned, and 312 were analyzed: 25% of respondents were in academic practice and 75% were in private practice. The majority were in practice more than 10 years. Nearly 80% begin surveillance colonoscopy at 8 to 10 years of disease duration for patients with pancolitis, and 54% report sending at least 31 biopsy specimens. Sixty percent of respondents did not recommend immediate colectomy for a confirmed finding of low-grade dysplasia, instead opting for repeat colonoscopy in 3 to 12 months. Physicians who took fewer biopsy specimens were more likely to recommend continued surveillance for low-grade dysplasia compared with those who took a greater number of biopsy specimens. Limitations: Limitations included the response rate of 33% and the potential for recall bias. Conclusions: Most U.S. gastroenterologists are practicing surveillance in patients with ulcerative colitis in accordance with published guidelines. There is widespread variation in the management of dysplasia and raised lesions, and the majority of U.S. gastroenterologists do not recommend immediate colectomy for a finding of low-grade dysplasia.

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume65
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Ulcerative Colitis
Colectomy
Colonoscopy
Biopsy
Private Practice
Practice Management
Practice Guidelines
Gastroenterologists
Guidelines
Physicians
Surveys and Questionnaires

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Surveillance and management of dysplasia in ulcerative colitis. / Rodriguez, Sarah A.; Collins, Judith (Judy); Knigge, Kandice; Eisen, Glenn M.

In: Gastrointestinal Endoscopy, Vol. 65, No. 3, 03.2007.

Research output: Contribution to journalArticle

Rodriguez, Sarah A. ; Collins, Judith (Judy) ; Knigge, Kandice ; Eisen, Glenn M. / Surveillance and management of dysplasia in ulcerative colitis. In: Gastrointestinal Endoscopy. 2007 ; Vol. 65, No. 3.
@article{5fa4494d299f4422ba44042f6ee5d0b7,
title = "Surveillance and management of dysplasia in ulcerative colitis",
abstract = "Background: Recently updated practice guidelines give specific recommendations on surveillance and management of dysplasia in patients with ulcerative colitis. Previous studies of gastroenterologists in the United States and the United Kingdom demonstrated inconsistent surveillance techniques and limited understanding of the implications of dysplasia. Objectives: To demonstrate current surveillance practices and management of dysplasia among U.S. gastroenterologists. Design: An 18-item questionnaire was mailed to 1000 gastroenterologists in the United States who were randomly selected from an American Gastroenterological Association mailing list. Setting: United States. Results: A total of 334 questionnaires were returned, and 312 were analyzed: 25{\%} of respondents were in academic practice and 75{\%} were in private practice. The majority were in practice more than 10 years. Nearly 80{\%} begin surveillance colonoscopy at 8 to 10 years of disease duration for patients with pancolitis, and 54{\%} report sending at least 31 biopsy specimens. Sixty percent of respondents did not recommend immediate colectomy for a confirmed finding of low-grade dysplasia, instead opting for repeat colonoscopy in 3 to 12 months. Physicians who took fewer biopsy specimens were more likely to recommend continued surveillance for low-grade dysplasia compared with those who took a greater number of biopsy specimens. Limitations: Limitations included the response rate of 33{\%} and the potential for recall bias. Conclusions: Most U.S. gastroenterologists are practicing surveillance in patients with ulcerative colitis in accordance with published guidelines. There is widespread variation in the management of dysplasia and raised lesions, and the majority of U.S. gastroenterologists do not recommend immediate colectomy for a finding of low-grade dysplasia.",
author = "Rodriguez, {Sarah A.} and Collins, {Judith (Judy)} and Kandice Knigge and Eisen, {Glenn M.}",
year = "2007",
month = "3",
doi = "10.1016/j.gie.2006.07.034",
language = "English (US)",
volume = "65",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Surveillance and management of dysplasia in ulcerative colitis

AU - Rodriguez, Sarah A.

AU - Collins, Judith (Judy)

AU - Knigge, Kandice

AU - Eisen, Glenn M.

PY - 2007/3

Y1 - 2007/3

N2 - Background: Recently updated practice guidelines give specific recommendations on surveillance and management of dysplasia in patients with ulcerative colitis. Previous studies of gastroenterologists in the United States and the United Kingdom demonstrated inconsistent surveillance techniques and limited understanding of the implications of dysplasia. Objectives: To demonstrate current surveillance practices and management of dysplasia among U.S. gastroenterologists. Design: An 18-item questionnaire was mailed to 1000 gastroenterologists in the United States who were randomly selected from an American Gastroenterological Association mailing list. Setting: United States. Results: A total of 334 questionnaires were returned, and 312 were analyzed: 25% of respondents were in academic practice and 75% were in private practice. The majority were in practice more than 10 years. Nearly 80% begin surveillance colonoscopy at 8 to 10 years of disease duration for patients with pancolitis, and 54% report sending at least 31 biopsy specimens. Sixty percent of respondents did not recommend immediate colectomy for a confirmed finding of low-grade dysplasia, instead opting for repeat colonoscopy in 3 to 12 months. Physicians who took fewer biopsy specimens were more likely to recommend continued surveillance for low-grade dysplasia compared with those who took a greater number of biopsy specimens. Limitations: Limitations included the response rate of 33% and the potential for recall bias. Conclusions: Most U.S. gastroenterologists are practicing surveillance in patients with ulcerative colitis in accordance with published guidelines. There is widespread variation in the management of dysplasia and raised lesions, and the majority of U.S. gastroenterologists do not recommend immediate colectomy for a finding of low-grade dysplasia.

AB - Background: Recently updated practice guidelines give specific recommendations on surveillance and management of dysplasia in patients with ulcerative colitis. Previous studies of gastroenterologists in the United States and the United Kingdom demonstrated inconsistent surveillance techniques and limited understanding of the implications of dysplasia. Objectives: To demonstrate current surveillance practices and management of dysplasia among U.S. gastroenterologists. Design: An 18-item questionnaire was mailed to 1000 gastroenterologists in the United States who were randomly selected from an American Gastroenterological Association mailing list. Setting: United States. Results: A total of 334 questionnaires were returned, and 312 were analyzed: 25% of respondents were in academic practice and 75% were in private practice. The majority were in practice more than 10 years. Nearly 80% begin surveillance colonoscopy at 8 to 10 years of disease duration for patients with pancolitis, and 54% report sending at least 31 biopsy specimens. Sixty percent of respondents did not recommend immediate colectomy for a confirmed finding of low-grade dysplasia, instead opting for repeat colonoscopy in 3 to 12 months. Physicians who took fewer biopsy specimens were more likely to recommend continued surveillance for low-grade dysplasia compared with those who took a greater number of biopsy specimens. Limitations: Limitations included the response rate of 33% and the potential for recall bias. Conclusions: Most U.S. gastroenterologists are practicing surveillance in patients with ulcerative colitis in accordance with published guidelines. There is widespread variation in the management of dysplasia and raised lesions, and the majority of U.S. gastroenterologists do not recommend immediate colectomy for a finding of low-grade dysplasia.

UR - http://www.scopus.com/inward/record.url?scp=33847063907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847063907&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2006.07.034

DO - 10.1016/j.gie.2006.07.034

M3 - Article

C2 - 17321245

AN - SCOPUS:33847063907

VL - 65

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 3

ER -